Drug-induced hypersensitivity syndrome caused by carbamazepine used for the treatment of trigeminal neuralgia

8Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An 88-year-old man was diagnosed with trigeminal neuralgia, and treatment of carbamazepine 200 mg/day was initiated. About 6 weeks later, the patient developed a skin rash accompanied by fever. He was admitted to hospital and diagnosed with drug-induced hypersensitivity syndrome (DIHS) caused by carbamazepine. Oral carbamazepine treatment was stopped, but blood tests showed acute liver and acute renal failure. Drug-induced lymphocyte stimulation test (DLST) for carbamazepine, human herpes virus-6 (HHV-6) IgG, and CMV-HRP were negative. Oral prednisolone therapy was begun 18 days later. The titer of HHV-6 IgG antibodies was then detected (640 times). Following treatment, liver and renal function improved and the erythema disappeared.

Cite

CITATION STYLE

APA

Ono, Y., Shimo, T., Shirafuji, Y., Hamada, T., Masui, M., Obata, K., … Sasaki, A. (2016). Drug-induced hypersensitivity syndrome caused by carbamazepine used for the treatment of trigeminal neuralgia. Case Reports in Dentistry, 2016. https://doi.org/10.1155/2016/4605231

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free